Anchun International Holdings Ltd (SGX:BTX), which has zero-debt on ... capital returns make sense if BTX is a high-growth company. BTX’s revenue growth over the past year is a double-digit ...

Today we are going to look at Anchun International Holdings Ltd. (SGX:BTX) to see whether it might ... much pre-tax income (in percentage terms) a company earns on the capital invested in its ...

Botanix Pharmaceuticals Ltd (ASX:BOT) (OTCMKTS:BXPHF ... rosacea and is expanding the study design to start early next quarter. BTX 1702 leverages the company’s proprietary drug delivery system ...

“It allows us at BTX Group to focus 100% on our classic division,” he added. DK Company, which already owns young fashion brands including Kaffe, Cream and Kön & Mön, will become the third-largest ...

BTX and its subsidiary Cell Cure Neurosciences Ltd.(Cell Cure) have entered into a share purchase agreement through which BTX agreed to purchase 87,456 Cell Cure ordinary shares in exchange for ...

Botanix Pharmaceuticals Ltd (ASX:BOT ... have become very difficult to treat. “The company has worked diligently to complete the BTX 1801 Phase 2a study despite the significant disruption ...

Anchun International Holdings Ltd (SGX:BTX), which has zero-debt on its balance sheet ... Choosing financial flexibility over capital returns make sense if BTX is a high-growth company. BTX’s revenue ...